French drugmaker Sanofi pledged more cost cuts to increase margins as it relies ever more on its star eczema treatment to boost earnings, in the face of pressure to come up with a COVID-19 vaccine to tackle the global pandemic. Ciara Lee reports
01:12
01:08
02:22
02:48
01:14
01:30
01:14
00:19
02:05
00:37
01:51
01:02
00:42
01:07
02:17
02:26
01:25
01:22
01:14
01:15
02:22
02:22
01:07
01:14
01:33
01:02
02:16
02:19
01:18
01:35
01:29
01:28
01:40
01:12
01:03
01:43
02:09
01:42
01:26
01:07
01:08
00:19
00:42
01:06
00:24
00:24
00:44
01:47
01:07
00:21
01:41
01:17
00:56
01:05
01:34
00:50
01:34
01:27
00:42
01:09
02:17
00:45
01:48
01:35
01:06
01:46
02:20
01:01
01:13
01:10
01:00
01:50
01:03
01:55
01:47
02:04
01:23
03:24
01:39
00:23
02:27
01:30
01:51
01:43
01:07
00:44
02:27
01:29
00:52
02:00
02:00
01:04
01:19
00:47
01:26
01:13
01:22
01:22
01:15
01:20